- Home
- DHC vs PLRX Comparison
DHC vs PLRX Comparison
Compare DHC & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHC
- PLRX
- Stock Information
- Founded
- DHC 1998
- PLRX 2015
- Country
- DHC United States
- PLRX United States
- Employees
- DHC N/A
- PLRX N/A
- Industry
- DHC Real Estate Investment Trusts
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- DHC Real Estate
- PLRX Health Care
- Exchange
- DHC Nasdaq
- PLRX Nasdaq
- Market Cap
- DHC 856.4M
- PLRX 89.0M
- IPO Year
- DHC N/A
- PLRX 2020
- Fundamental
- Price
- DHC $4.43
- PLRX $1.53
- Analyst Decision
- DHC Sell
- PLRX Hold
- Analyst Count
- DHC 1
- PLRX 10
- Target Price
- DHC $3.00
- PLRX $3.93
- AVG Volume (30 Days)
- DHC 708.7K
- PLRX 725.5K
- Earning Date
- DHC 11-03-2025
- PLRX 11-06-2025
- Dividend Yield
- DHC 0.90%
- PLRX N/A
- EPS Growth
- DHC N/A
- PLRX N/A
- EPS
- DHC N/A
- PLRX N/A
- Revenue
- DHC $1,522,835,000.00
- PLRX N/A
- Revenue This Year
- DHC $4.32
- PLRX N/A
- Revenue Next Year
- DHC $3.21
- PLRX N/A
- P/E Ratio
- DHC N/A
- PLRX N/A
- Revenue Growth
- DHC 4.29
- PLRX N/A
- 52 Week Low
- DHC $2.00
- PLRX $1.10
- 52 Week High
- DHC $4.56
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- DHC 73.01
- PLRX 44.68
- Support Level
- DHC $4.20
- PLRX $1.66
- Resistance Level
- DHC $3.91
- PLRX $1.85
- Average True Range (ATR)
- DHC 0.18
- PLRX 0.13
- MACD
- DHC 0.06
- PLRX -0.02
- Stochastic Oscillator
- DHC 84.89
- PLRX 12.20
About DHC Diversified Healthcare Trust of Beneficial Interest
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.